- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.03. | U.S. lawmakers reportedly question FDA over Neuralink inspections | ||
| 27.03. | Synaptive Medical wins FDA nod for near-infrared fluorescence in robotic exoscope | ||
| 27.03. | SyntheticMR wins FDA clearance for 3D brain scanner | ||
| 27.03. | FDA wants to ban electrical stimulation devices for self-injurious, aggressive behavior | ||
| 27.03. | FDA approves next-gen Evolut TAVR system from Medtronic | ||
| 27.03. | Edwards Lifesciences' chair Michael Mussallem retires from board | ||
| 26.03. | Shockwave Medical is reportedly a J&J acquisition target | ||
| 26.03. | FDA clears redesigned kidney stone treatment tech from Calyxo | ||
| 26.03. | Stryker launches hip fracture nailing system in Europe | ||
| 26.03. | Protembis raises $32.6M, adds Shockwave exec to board | ||
| 26.03. | PathKeeper Surgical, Mayo Clinic sign know-how agreement for pediatric spine surgery radiation research | ||
| 26.03. | NeuroOne begins neuroablation system launch in U.S. | ||
| 26.03. | Boston Scientific, Scivita partner on endoscopic devices | ||
| 25.03. | GE HealthCare to distribute newly FDA-cleared remote patient support tech | ||
| 25.03. | Fast Company names 10 medtech companies as most innovative of 2024 | ||
| 25.03. | Precision Neuroscience launches new BCI study sites | ||
| 25.03. | Abbott wins CE mark for insertable cardiac monitor | ||
| 25.03. | FDA clears Neuronetics' neurostim for adolescents with depression | ||
| 25.03. | Axonics stockholders approve Boston Scientific acquisition | ||
| 25.03. | J&J's Biosense Webster submits Varipulse pulsed field ablation system for FDA approval | ||
| 22.03. | Masimo looks to separate consumer business two years after $1 billion buyout | ||
| 22.03. | Revamp Medical names Mike Favet as CEO | ||
| 22.03. | Biotronik wins breakthrough nod for Freesolve BTK resorbable magnesium scaffold | ||
| 22.03. | Bessel launches accelerator program for medtech startups | ||
| 21.03. | PTAB upholds two Medtronic patents in spat with Axonics, could go to jury trial |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
